Overall and subgroup 5-year incidence rate (person per 1000 person-years) of anxiety and depressive symptoms among the adult population in Kerman, Iran, community-based cohort study (KERCADRS, first phase, 2009–2012, and second phase, 2014–2018; n=2813 match cases)
| Subgroups | Anxiety | Depression | ||||
| New cases | Person-years | Incidence rate (95% CI) | New cases | Person-years | Incidence rate (95% CI) | |
| Overall | 97 | 6466.5 | 15.0 (12.2 to 18.3) | 27 | 6923.5 | 3.9 (2.6 to 5.7) |
| Sex | ||||||
| Male | 53 | 4250.5 | 12.5 (9.3 to 16.3) | 10 | 3571 | 2.8 (1.3 to 5.2) |
| Female | 44 | 2210.5 | 19.9 (14.5 to 26.7) | 17 | 3269.5 | 5.2 (3.0 to 8.3) |
| Educational level | ||||||
| Illiterate | 9 | 482.5 | 18.7 (8.5 to 35.4) | 2 | 526 | 3.8 (0.5 to 13.7) |
| Primary | 16 | 897.5 | 17.8 (10.2 to 29.0) | 7 | 1093.5 | 6.4 (2.6 to 13.2) |
| Secondary | 48 | 3252.5 | 14.8 (10.9 to 19.6) | 13 | 3513.5 | 3.7 (2.0 to 6.3) |
| University | 24 | 1832.5 | 13.1 (8.4–19.5) | 5 | 1666.5 | 3.0 (1.0 to 7.0) |
| Cigarette smoke | ||||||
| No | 89 | 5629 | 15.8 (12.7 to 19.5) | 25 | 6097.5 | 4.1 (2.7 to 6.1) |
| Yes | 8 | 575 | 13.9 (6.0 to 27.4) | 2 | 859 | 2.3 (0.3 to 8.4) |
| Opium use | ||||||
| No | 84 | 5250.5 | 16.0 (12.8 to 19.8) | 23 | 6052.5 | 3.8 (2.4 to 5.7) |
| Yes | 13 | 928.5 | 14.0 (7.4 to 23.9) | 4 | 793.5 | 5.0 (1.4 to 12.9) |
| Physical activity | ||||||
| Low | 47 | 2737.5 | 17.2 (12.6 to 22.8) | 14 | 2916.5 | 4.8 (2.6 to 8.1) |
| Moderate | 31 | 2912.5 | 10.6 (7.2 to 15.1) | 10 | 3289.5 | 3.0 (1.5 to 5.6) |
| High | 19 | 840 | 22.6 (13.6 to 35.3) | 3 | 739.5 | 4.1 (0.8 to 11.9) |
| BMI | ||||||
| Normal | 34 | 3591.5 | 9.5 (6.6 to 13.2) | 8 | 3076 | 2.6 (1.1 to 5.1) |
| Overweight | 27 | 1925 | 14.0 (9.2 to 20.4) | 10 | 2325.5 | 4.3 (2.1 to 7.9) |
| Obese | 36 | 917.5 | 39.2 (27.5 to 54.3) | 9 | 1451.5 | 6.2 (2.8 to 11.8) |
BMI, Body Mass Index; KERCADRS, Kerman Coronary Artery Disease Risk Factors Study.